Body composition changes in treatment-experienced HIV-infected patients initiating a tenofovir-containing antiretroviral regimen

被引：0
|
作者：
Tsekes, G
Mangafas, N
Tsogas, N
Psathas, C
Vlachadami, I
Batakis, N
Lazanas, MC
机构：
[1] Red Cross Hosp, Dept Internal Med 3, Athens, Greece
[2] Red Cross Hosp, Infect Dis Unit, Athens, Greece
[3] Red Cross Hosp, Dept Radiol, Athens, Greece
来源：
ANTIVIRAL THERAPY | 2004年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
046
引用
收藏
页码：L29 / L30
页数：2
相关论文
共 50 条
  • [1] Body composition changes in treatment-experienced HIV-infected patients initiating an atazanavir-containing antiretroviral regimen
    Tsekes, G.
    Chini, M.
    Lioni, A.
    Tsogas, N.
    Mangafas, N.
    Boboli, M.
    Lazanas, M. C.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L23 - L23
  • [2] Body composition changes one year after switching to a tenofovir-containing antiretroviral regimen
    Tsekes, G
    Mangafas, N
    Tsogas, N
    Chini, M
    Salpigtis, J
    Nikolakopoulou, M
    Flessas, N
    Batakis, N
    Lazanas, MC
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S247 - S248
  • [3] Body composition changes in treatment-experienced HIV-infected patients: 10 years of follow-up
    Tsekes, G
    Mangafas, N
    Tsogas, N
    Salpigktis, I
    Batakis, N
    Georgiou, V
    Lazanas, MC
    ANTIVIRAL THERAPY, 2004, 9 (06) : L31 - L31
  • [4] Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa
    Kamkuemah, Monika
    Kaplan, Richard
    Bekker, Linda-Gail
    Little, Francesca
    Myer, Landon
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 (04) : 518 - 526
  • [5] Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients
    Gagliardini, Roberta
    Fabbiani, Massimiliano
    Colafigli, Manuela
    D'Avino, Alessandro
    Mondi, Annalisa
    Borghetti, Alberto
    Lamonica, Silvia
    Cauda, Roberto
    De Luca, Andrea
    Di Giambenedetto, Simona
    JOURNAL OF CHEMOTHERAPY, 2017, 29 (05) : 299 - 307
  • [6] Characteristics of Treatment-experienced HIV-infected African Children and Adolescents Initiating Darunavir and/or Etravirine-based Antiretroviral Treatment
    Corrigan, Bethany
    Mukui, Irene
    Mulenga, Lloyd
    Mthethwa, Nobuhle
    Letsie, Mosilinyane
    Bruno, Stephanie
    Rakhmanina, Natella
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (07) : 669 - 672
  • [7] High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy
    Bonjoch, Anna
    Echeverria, Patricia
    Perez-Alvarez, Nuria
    Puig, Jordi
    Estany, Carla
    Clotet, Bonaventura
    Negredo, Eugenia
    ANTIVIRAL RESEARCH, 2012, 96 (01) : 65 - 69
  • [8] THE ECONOMIC IMPACT OF MARAVIROC FOR ANTIRETROVIRAL TREATMENT-EXPERIENCED HIV-INFECTED INDIVIDUALS IN MEXICO
    Contreras-Hernandez, I
    Rely, K.
    Mould-Quevedo, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2009, 12 (03) : A116 - A116
  • [9] Safety and efficacy of lopinavir/ritonavir (LPV/r) and tenofovir (TDF) in treatment-experienced HIV-infected patients
    Cimoch, PJ
    Ruane, P
    Mathews, C
    Tat, SM
    Luber, AD
    Ballard, C
    Okamoto, C
    Kakuda, TN
    XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE, 2002, : 157 - 161
  • [10] Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: The TENOPLUS study
    Dominguez, Stephanie
    Ghosn, Jade
    Peytavin, Gilles
    Izzedine, Hassan
    Wirden, Marc
    Ktorza, Nadine
    Miller, Michael
    Aubron-Olivier, Camille
    Trylesinski, Aldo
    Calvez, Vincent
    Deray, Gilbert
    Katlama, Christine
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (02) : 105 - 110
12345